Calcium pyrophosphate crystal deposition affecting the cartilaginous structures of the vertebral column, classified as 'other' chondrocalcinosis when it does not meet criteria for familial (M11.18) or hydroxyapatite (M11.08) subtypes.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Spine
Documentation tips
What should appear in the chart to support M11.28.
Source · Editorial brief grounded in 5 cited references ↓
- Provider must explicitly document 'chondrocalcinosis' or 'CPPD' at the vertebral level — incidental radiographic calcification alone does not support M11.28 without a clinical diagnosis.
- Record the imaging modality (CT, MRI, or X-ray) and the specific finding (e.g., calcification of annulus fibrosus, ligamentum flavum, or facet joint cartilage) to substantiate the vertebral site.
- Distinguish the subtype in the note: if familial CPPD, use M11.18; if hydroxyapatite deposition disease at the spine, use M11.08; if neither, M11.28 is correct.
- Document spinal region affected (cervical, thoracic, lumbar, sacral) even though M11.28 does not require a regional sub-digit — payer audit reviewers and clinical documentation reviewers expect anatomic specificity in the note.
- If concurrent peripheral joint chondrocalcinosis is also active and separately managed, assign additional site-specific M11.2x codes or M11.29 for multiple sites as supported by documentation.
Related CPT procedures
Procedure codes commonly billed with M11.28. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M11.28 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M11.28 for incidental spinal calcification on imaging without a provider-documented diagnosis of chondrocalcinosis — the code requires a clinical diagnosis, not just a radiographic finding.
- Confusing M11.28 (other chondrocalcinosis, vertebrae) with M11.08 (hydroxyapatite deposition disease, vertebrae) — hydroxyapatite and CPPD are distinct crystal types requiring separate codes; provider documentation of crystal type determines the correct parent subcategory.
- Substituting M11.29 (multiple sites) when only vertebral involvement is documented — use M11.28 unless the provider explicitly documents simultaneous involvement of multiple joint sites.
- Selecting a peripheral joint M11.2x code (e.g., knee or hip) when imaging describes calcification near a vertebral end plate or disc — chondrocalcinosis is a joint/cartilage disease; always code to the documented anatomic site.
- Failing to code an underlying metabolic condition (e.g., hyperparathyroidism, hemochromatosis) when the provider identifies it as causally related — secondary crystal arthropathy may require additional diagnosis codes to capture the etiology fully.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M11.28 codes other chondrocalcinosis localized to the vertebrae — specifically, calcium pyrophosphate dihydrate (CPPD) crystal deposition in the fibrocartilage or hyaline cartilage of the spinal column that is not familial and not hydroxyapatite in nature. Use it when imaging (CT, MRI, or plain film) demonstrates calcification in spinal disc fibrocartilage, facet joint cartilage, or ligamentum flavum and the clinical documentation does not support a familial subtype or a metabolic disease that would require an underlying condition coded first.
Within the M11 category, vertebral chondrocalcinosis sits alongside site-specific codes for other crystal arthropathies. The spine-specific '8' site designator (M11.28) distinguishes vertebral involvement from peripheral joint involvement — do not substitute a peripheral joint code when the documented site is the spine. If multiple spinal and non-spinal joints are affected, consider M11.29 (multiple sites) only when documentation explicitly supports polyarticular involvement.
Chondrocalcinosis is classified as an arthropathy, not a bone disorder. Radiographic calcification noted incidentally in spinal soft tissue is insufficient alone — the provider must document a clinical diagnosis of chondrocalcinosis or CPPD at the vertebral level. Incidental calcification without a clinical diagnosis should not be coded M11.28; instead, code the finding as an abnormal imaging result pending provider interpretation.
Sibling codes
Other billable codes under M11.2 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between M11.08, M11.18, and M11.28 for the vertebrae?
02Can M11.28 be used when chondrocalcinosis is found incidentally on imaging without a clinical diagnosis?
03Should I code M11.28 or M11.29 when a patient has both vertebral and knee chondrocalcinosis?
04Does M11.28 require a 7th character extension?
05Is there a laterality requirement for M11.28?
06When should an underlying metabolic condition be coded alongside M11.28?
07Which CPT imaging codes pair most commonly with M11.28 in a spine workup?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-/M11.28
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M11.2
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M11
- 05cdn-links.lww.comhttps://cdn-links.lww.com/permalink/css/a/css_17_9_2016_06_07_lee_1_sdc1.pdf
Mira AI Scribe
Mira AI Scribe captures the provider's explicit diagnosis of vertebral chondrocalcinosis, the imaging modality and specific finding (e.g., calcification of ligamentum flavum or annulus fibrosus on CT lumbar spine), the spinal region involved, and any documented crystal subtype or metabolic etiology. This prevents downcoding to an unspecified crystal arthropathy, avoids conflation with hydroxyapatite disease (M11.08), and flags when an underlying metabolic condition should be co-coded.
See how Mira captures M11.28 documentation